TrialCancer2018

Phase 2 study of treatment selection based on tumor thymidylate synthase expression in previously untreated patients with metastatic colorectal cancer: A trial of the ECOG-ACRIN Cancer Research Group (E4203).

Neal J Meropol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.